From Burnout to Balance: The Role of CBD in Workplace Stress

In today's demanding and uber-productive work environments, everyday stress is normal and sometimes positive. But over time, ongoing workplace pressure and tension leads to burnout, emotional exhaustion, detachment, reduced efficiency and significantly diminished quality of life. With few options for treatment, research is considering CBD as a promising strategy for managing work-related stress, minimizing burnout and enhancing well-being. Here's what the science shows.

Everyday Stress vs Burnout Syndrome

Normal work-related stress as a reaction to deadlines or challenges, is transient, manageable and even beneficial, fueling motivation, productivity and a sense of accomplishment. Burnout is different. Unlike short-term stress, it's severe and persistent, with weighty consequences. Burnout syndrome is marked by an extreme state of emotional, physical and mental exhaustion, overwhelm, loss of productivity, and feelings of cynicism, hopelessness and despair. Symptoms include fatigue, frequent headaches, changes in appetite, gastrointestinal disturbances, insomnia, anxiety, irritability and impaired immunity. In acute cases, workplace tension and burnout are linked with higher rates of posttraumatic stress disorder (PTSD), serious depression and suicide. And it's alarmingly prevalent: some data shows two-thirds of U.S. employees are currently experiencing burnout, and 83 percent of younger workers reported burnout in 2025.^1–4

Existing treatments for burnout are sparse and limited. Cognitive-behavioral therapies and lifestyle changes are difficult to implement and often lacking in accessibility. Pharmacological interventions, primarily antidepressants and anxiolytic medications, typically require weeks or even months to take effect and many are associated with numerous and significant adverse events. As research focuses on safe, successful alternatives, a growing body of evidence points to CBD's potential for addressing work-related stress and burnout and improving quality of life.

Symptoms of Workplace Stress and Burnout: How CBD Helps

Emotional Exhaustion

Characterized by feeling drained, depleted, worn out and overwhelmed, emotional exhaustion is a core symptom of burnout. CBD is known to interact with the endocannabinoid system (ECS), influencing serotonin receptors and the HPA axis, and its ability to indirectly increase anandamide levels may support mood and relieve emotional exhaustion. In a randomized clinical trial of 120 frontline health care professionals working with COVID-19 patients, CBD treatment led to significant decreases in emotional exhaustion and corresponding symptoms of anxiety and depression in 14 days, and researchers concluded CBD was effective in alleviating emotional exhaustion and burnout.^5–11

Anxiety and Stress

CBD has been widely examined for its anxiolytic properties, and its potential for calming feelings of worry and distress offers a promising approach to work-related burnout. Studies using functional MRI demonstrate CBD's ability to blunt activity in the amygdala, impact cerebral blood flow and reduce resting-state activity and connectivity across several brain regions. Human studies show its positive effects on stress and anxiety, and in research on patients diagnosed with anxiety disorders, CBD was linked with decreases in anxiety and improvements in well-being.^12–19

Depression

Workplace stress and burnout drive negative feelings and low mood; through various mechanisms, CBD may help manage depression and promote balance. CBD interacts with the gut-brain axis, regulating neurotransmitter production, affecting the vagus nerve and modulating gut inflammation associated with depression and mood disorders. Other research shows its ability to influence the serotonergic system and inhibit neuroinflammation, and preliminary clinical trials support its use in addressing depression and mood disorders. Unlike traditional pharmaceutical interventions, CBD acts quickly, with some studies suggesting it may take effect in as little as seven days.^20–28

Sleep Disturbances

Stress and anxiety fuel insomnia, and sleep deprivation further exacerbates emotional exhaustion and burnout, creating a vicious and hard-to-break cycle. Via its involvement with the ECS—known to play a critical role in sleep architecture—CBD has been shown to regulate sleep-wake cycles and improve a range of sleep parameters. In research on patients with depression and mood disorders, CBD had significant benefits on sleep, and clinical trials on healthy patients suggest CBD reduces sleep latency, increases sleep duration, minimizes night wakings and enhances overall sleep quality.^29–35

Post-Traumatic Stress Disorder (PTSD)

In extreme cases, chronic, excessive work-related stress can manifest in symptoms of PTSD. First responders, police officers, firefighters, emergency medical personnel and frontline healthcare workers are frequently exposed to traumatic events, and an estimated 30 percent of first responders develop behavioral health conditions, including PTSD. Preclinical research suggests CBD may play a role in managing symptoms of PTSD, in part by interacting with the ECS, and in some studies, CBD treatment was associated with reductions in anxiety, nightmares and other symptoms of PTSD.^36–43

References

1. González-Sanguino C et al. Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun. 2020;87:172-176.
2. Pappa S et al. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain Behav Immun. 2020;88:901-907.
3. Tang W et al. Prevalence and correlates of PTSD and depressive symptoms one month after the outbreak of the COVID-19 epidemic in a sample of home-quarantined Chinese university students. J Affect Disord. 2020;274:1-7.
4. Nguyen N et al. The Relationship Between Depression, Burnout, and Suicide Among Healthcare Professionals: A Scoping Review. Worldviews Evid Based Nurs. 2025;22(3):e70037.
5. Henson JD et al. Enhancing Endocannabinoid Control of Stress with Cannabidiol. J Clin Med. 2021;10(24):5852.
6. Viudez-Martínez A et al. Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress. J Psychopharmacol. 2018;32(12):1379-1384.
7. Lee JLC et al. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. Br J Pharmacol. 2017;174(19):3242-3256.
8. Fusar-Poli P et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009;66(1):95-105.
9. Hua DY et al. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Transl Psychiatry. 2023;13(1):131.
10. De Petrocellis L et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163(7):1479-1494.
11. Crippa JAS et al. Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(8):e2120603.
12. Oberbarnscheidt T, Miller NS. The Impact of Cannabidiol on Psychiatric and Medical Conditions. J Clin Med Res. 2020;12(7):393-403.
13. Schouten M et al. Cannabidiol and brain function: current knowledge and future perspectives. Front Pharmacol. 2024;14:1328885.
14. Crippa JA et al. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29(2):417-426.
15. Wright M et al. Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. Cannabis Cannabinoid Res. 2020;5(3):191-196.
16. Blessing EM et al. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825-836.
17. Bergamaschi MM et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36(6):1219-1226.
18. Dahlgren MK et al. Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. Commun Med (Lond). 2022;2(1):139.
19. Russo EB et al. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res. 2005;30(8):1037-1043.